Internal Medicine Alert - December 30, 2007

Target Audience:

This activity is intended for the internist and family practitioner.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Executive Editor
Stephen A. Brunton, MD

Clinical Professor
University of California, Irvine

Associate Editors
Barbara A. Phillips, MD, MSPH
Professor of Medicine
University of Kentucky
Director, Sleep Disorders Center
Samaritan Hospital
Lexington

Malcolm Robinson, MD, FACP, FACG
Emeritus Clinical Professor of Medicine
University of Oklahoma College of Medicine
Oklahoma City

William T. Elliott, MD, FACP
Chair, Formulary Committee
Northern California Kaiser Permanente
Asst. Clinical Professor of Medicine
University of California
San Francisco

James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Manager
Kaiser Permanente
Oakland, CA

Louis Kuritzky, MD
Clinical Assistant Professor
University of Florida
Gainesville

Peer Reviewer
Gerald Roberts, MD
Assistant Clinical Professor of Medicine
Albert Einstein College of Medicine
New York, NY

Authors
Leon Speroff, MD
Editor, OB/GYN Clinical Alert

William B. Ershler, MD INOVA Fairfax Hospital Cancer Center
Fairfax, VA
Director
Institute for Advanced Studies in Aging
Washington, DC

Subjects:

  • 'Tis the Season
  • Use of Proton Pump Inhibitors and Other Acid Suppressive Medications in Newly Admitted Nursing Facility Patients
  • Intravenous Bisphosphonate and Facial Bones
  • Diagnosing Early Pancreatic Cancer
  • Sorafenib Tablets(Nexavar®)
  • Clinical Briefs by Louis Kuritzky, MD

Objectives:

  • describe new findings in differential diagnosis and treatment of various diseases
  • describe controversies, advantages, and disadvantages of those advances
  • describe cost-effective treatment regimens
  • describe the pros and cons of new screening procedures.

Financial Disclosure:

Internal Medicine Alert's editor, Stephen Brunton, MD, is a consultant for Abbott, Amylin, Boehringer Ingelheim, Eli Lilly, Endo, Novartis, and Novo Nordisk. Associate editors Barbara A. Phillips, MD, MSPH, Malcolm Robinson, MD, FACP, FACG, William T. Elliott, MD, FACP, James Chan, PharmD, PhD and peer reviewer Gerald Roberts, MD, report no financial relationships to this field of study. Author Leon Speroff, MD is the Editor of OB/GYN Clinical Alert. He is a consultant for Warner Chilcott. Author William B. Ershler, MD is on the speaker's bureau for Wyeth and does research for Ortho Biotech. Associate editor Louis Kuritzky, MD is a consultant for GlaxoSmithKline and is on the speaker's bureau of GlaxoSmithKline, 3M, Wyeth-Ayerst, Pfizer, Novartis, Bristol-Myers Squibb, AstraZeneca, Jones Pharma, and Boehringer Ingelheim. .

Copyright 2007 AHC Media. All rights reserved.